[Suppression of rhinovirus infections with macrolide antibiotics].
Yamatani
Mutsuo
M
Suzuki
Tomoko
T
Sasaki
Akihiko
A
Yasuda
Hiroyasu
H
Inoue
Daisuke
D
Sasaki
Hidetada
H
D000368:Aged; D002478:Cells, Cultured; D003139:Common Cold / Q000517:prevention & control*; D004847:Epithelial Cells / Q000378:metabolism / Q000821:virology*; D004917:Erythromycin / Q000494:pharmacology* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics / Q000378:metabolism; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive; D012367:RNA, Viral / Q000378:metabolism; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism; D011991:Receptors, Virus / Q000378:metabolism; D012229:Rhinovirus / Q000235:genetics / Q000502:physiology*; D014132:Trachea / Q000378:metabolism / Q000821:virology*; D014779:Virus Replication / Q000187:drug effects*
D012367:RNA, Viral; D011973:Receptors, LDL; D011991:Receptors, Virus; D018799:Intercellular Adhesion Molecule-1; D004917:Erythromycin